Martha Raymond, Founder and CEO of the GI Cancers Alliance and Raymond Foundation, shared on LinkedIn:
“I enjoyed our ‘Big Questions’ discussion and look forward to working together again as we continue to address the issues that shape cancer research, treatment and patient access.
Thank you to Amalya Sargsyan and OncoDaily for the invitation to participate in this important conversation.
Held on October 24 in Madrid during ESMO 2026, the OncoDaily discussion brought together leading voices from across the oncology community.
Chaired by Jean-Yves Blay, the session featured Julie Gralow, Martha Raymond and Jennifer S. Buell, bringing perspectives from clinical leadership, cancer policy, patient advocacy and the biopharmaceutical industry.
The discussion highlighted the importance of collaboration and shared responsibility in advancing cancer care.”
You can also read: A Defining Moment for Cancer Immunotherapy During ESMO 2026 – Agenus
